The estimated intrinsic value of Sabra Health Care REIT, Inc. (SBRA) using a Price-to-Funds From Operations (P/FFO) model is $18.78 (based on the recommended P/FFO method), compared to the current stock price of $20.34. This suggests the stock may be overvalued by 7.7% relative to its intrinsic value.

For Real Estate Investment Trusts (REITs), standard DCF models can be misleading because depreciation — a large non-cash charge — distorts net income. Instead, SharesGrow uses a Price-to-FFO (Funds From Operations) model: Intrinsic Value = FFO Per Share × 17 (sector-average P/FFO multiple). FFO adds back depreciation to net income, providing a more accurate picture of a REIT's recurring cash-generating ability — the industry-standard metric for REIT valuation.

The valuation uses a CAPM-derived discount rate of 4.59% (CAPM-derived from beta of 0.65). For comparison, the standard 20-year DCF model produces: Operating Cash Flow (OCF): $23.96 | Free Cash Flow (FCF): $23.96 | Net Income (NI): $5.49.